Dr Paul Young is an Intensive Care Specialist at Wellington Hospital in New Zealand. He is the Programme Director of the Medical Research Institute of New Zealand’s Intensive Care Research Programme. Despite only seven years of research experience, Dr Young has established himself as a highly recognised figure in the field of clinical ICU research internationally with more than 80 peer-reviewed publications, including two JAMA publications and three publications in the New England Journal of Medicine. He has more than $25M of current research funding and is involved in research collaborations with investigators from Australia, the UK, Canada, the USA, Italy, Scandinavia, and Brazil. He is the Chief Investigator for the ICU-ROX trial, the REACTOR trial, and the PEPTIC trial which are all on-going. He completed his PhD thesis investigating treatment of fever in critically ill patients with suspected infections in 2016 and holds a Health Research Council of New Zealand Clinical Practitioner Fellowship to support his research in fever management in the critically ill.